Le Lézard
Classified in: Health
Subjects: AWD, BFA, VET

VITAS Healthcare is Georgia's First Hospice Provider to Receive Nation's Highest Recognition for its Dedication to Atlanta's Veterans


ATLANTA, Jan. 30, 2020 /PRNewswire/ -- VITAS® Healthcare, the nation's leading provider of end-of-life care, is recognized in Atlanta as an elite Level 5 Partner of the We Honor Veterans (WHV) initiative through the National Hospice and Palliative Care Organization (NHPCO) and the Department of Veteran Affairs (VA).

The achievement marks the state of Georgia's first Level 5 hospice company as well as VITAS' first service area to attain WHV's highest rank.

To attain Level 5 status, the VITAS team in Atlanta completed activities designed to increase access and improve quality of care for veterans in the local community, such as conducting veteran-specific presentations, evaluating and reporting on demographics of veterans served by the organization, and developing procedures for transitioning veterans across a continuum of care.

Unlike Levels 1 through 4, Level 5 partner status requires annual recertification by organizations to maintain the designation. Level 5 places a greater emphasis on staff education and efforts to meet the unique needs of Vietnam-era and combat veterans. Level 5 partners also assume the role of regional mentors to other WHV partners as they work toward higher Levels.

"VITAS excels at veteran care in part because so many members of our leadership team and staff are veterans and have a big heart for their fellow servicemembers," said Larry Robert, a former Navy chaplain and manager of bereavement and veteran services for VITAS in Atlanta. "We're looking forward to helping other members reach our level of expertise and further their commitment to our nation's heroes. This includes helping partners outside of VITAS, because reaching Level 5 is about veterans getting the support they deserve."

To commemorate VITAS' achievement, WHV presented the hospice provider with an award letter and certificate in December 2019.

"Achieving Level 5 is not a one-time deal. Earning this highest level of recognition encourages our continued support of veterans, and at VITAS, keeping our Level 5 rank demonstrates our commitment," Robert said. "We are proud to be recognized with this important accolade and a part of this effort and to be with the first city in the state and organization to reach this goal."

WHV is a collaboration between the NHPCO and the VA dedicated to providing educational tools and resources to hospice providers and VA facilities. Dozens of VITAS locations throughout the country maintain Level 1-4 partnerships with WHV.

The VITAS office in Atlanta provides quality compassionate care to terminally ill patients throughout 20 counties in and surrounding Atlanta.

About VITAS® Healthcare

Established in 1978, VITAS Healthcare is a pioneer and leader in the American hospice movement. Headquartered in Miami, Florida, VITAS (pronounced VEE-tahs) operates 48 hospice programs in 14 states (California, Connecticut, Delaware, Florida, Georgia, Illinois, Kansas, Missouri, New Jersey, Ohio, Pennsylvania, Texas, Virginia and Wisconsin) and the District of Columbia. VITAS employs 12,388 professionals who care for terminally ill patients daily, primarily in the patients' homes, and also in the company's 28 inpatient hospice units as well as in hospitals, nursing homes and assisted living communities/residential care facilities for the elderly. At the conclusion of the third quarter of 2019, VITAS reported an average daily census of 19,137. Visit www.vitas.com.

Media Inquiries contact: [email protected], 877-848-2701

In Atlanta, VITAS Healthcare became the first hospice in Georgia to earn the elite Level 5 partner status in the We Honor Veterans initiative.

Established in 1978, VITAS Healthcare is the nation's leading provider of end-of-life care. For more information, visit VITAS.com. (PRNewsfoto/VITAS Healthcare)

SOURCE VITAS Healthcare


These press releases may also interest you

at 07:08
Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announce the successful initiation and first two patients enrollment for its global multicenter...

at 07:05
Bruker Corporation is pleased to announce the successful installation of a 1.2 GHz NMR spectrometer at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, accepted in the second quarter of 2024. This ultra-high field NMR...

at 07:05
KORU Medical Systems, Inc. ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today...

at 07:05
Satellos Bioscience Inc. ("Satellos" or the "Company") , a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, today announced preliminary results from a single case...

at 07:00
ThirtyFiveBio Limited,...

at 07:00
DRI Healthcare Trust (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, has acquired a second royalty interest in the worldwide net sales of Xenpozyme (olipudase alfa) from HLS...



News published on and distributed by: